Edited By : Renée Deveney
This page features 7 Cited Research Articles
Fact Checked
Fact-Checked

Editors carefully fact-check all Consumer Notice, LLC content for accuracy and quality.

Consumer Notice, LLC has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Dexcom Lawsuit 2026 Updates and News

So far, people have filed several Dexcom G6 and G7 lawsuits, but they are in the early stages. No public settlements or trials have been scheduled. Lawyers continue to accept new cases.

Two class actions have been filed in this litigation. The first was created for consumers who want refunds for the price of their Dexcom CGMs, and the second was made on behalf of investors.

For the second class action, the deadline for the lead plaintiff complaint is Dec. 26, 2025.

Why Are People Filing Dexcom G7 and G6 Lawsuits?

People are filing lawsuits against Dexcom G7 and G6 CGMs because they say the devices are prone to inaccurate readings and alert failures.

Furthermore, plaintiffs say the CGMs are defectively designed, leading to injuries caused by undetected dangerous blood sugar levels.

Dexcom Lawsuit Claims
Failure To Warn:
Dexcom didn’t properly warn the public about the risk of hypoglycemic/hyperglycemic events and other serious injuries, including death, linked to using the Dexcom G6 and G7.
Defective Design:
Lawsuits claim that the G6 and G7 are defectively designed and can fail to alert people, causing serious and potentially life-threatening injuries.
Negligence:
Dexcom failed to properly market, test or design its CGMs to minimize the risk of unreasonable and dangerous injuries.

Plaintiffs who have already filed lawsuits say the devices can cause serious injuries, including death.

Dexcom G7 FDA Warning, Recalls and Safety Investigations

Dexcom initiated several recalls for its G6 and G7 CGMs in 2025, and the FDA also sent a warning letter to the company for failing to inform them of design changes.

Dexcom G6 and G7 Recalls

Dexcom’s 2025 G6 and G7 recalls were for defective speakers and malfunctioning Android apps. Both were Class I recalls, the most serious level, because these issues could lead to serious injury or death.

Dexcom Recalls in 2025
  • Dexcom recalled 333 Dexcom G6 CGMs in October 2025 because Android mobile apps may crash unexpectedly. This could stop people from getting glucose data or alarms for high or low blood sugar. According to Dexcom, these issues could delay treatment of dangerous blood sugar levels, diabetic ketoacidosis (DKA) and other complications. This was solved by an app update.
  • In June 2025, Dexcom recalled 602,445 G7 receivers and 36,824 G6 receivers worldwide because defective foam could have prevented the speaker from sounding high or low blood sugar alerts. This could lead to missed detection of severe hypoglycemia or hyperglycemia.

Potential injuries listed in these recalls include severe hypo or hyperglycemia, diabetic ketoacidosis, seizures, loss of consciousness and death.

How Dexcom G6 and G7 Receiver Recalls May Support Lawsuit Claims

Dexcom G6 and G7 receiver recalls may support lawsuit claims because the recalls cite defective foam or an assembly error, and they also talk about a software defect. These details could support defective design claims.

These recalls also specify the serious injuries that could happen because of these defects — such as hyper or hypoglycemia and diabetic ketoacidosis (DKA) — which are claimed in lawsuits.

FDA Warning: Dexcom Didn’t Properly Evaluate Design Changes

The FDA sent a warning letter to Dexcom in March 2025 telling the company that it did not properly evaluate or validate design changes that affected the resistance layers of its G6 and G7 CGM sensors.

According to the agency, Dexcom didn’t properly prove that the new and old designs were equivalent, and one of the designs seemed to be less accurate than the other.

Injuries Reported in Dexcom G7 and G6 Lawsuits

The main injuries in Dexcom G7 and G6 lawsuits are hypo or hyperglycemia and the complications that can occur from dangerous blood glucose levels.

Reported Injuries
  • Coma
  • Death
  • Diabetic ketoacidosis (DKA)
  • Hospitalization
  • Hyperglycemia
  • Hypoglycemia
  • Seizures

Wrongful Death Claims Potentially Linked to Dexcom Device Problems

Plaintiffs have also filed wrongful death claims linked to Dexcom device problems related to failure to alert and inaccurate readings.

Michael Schepers used a Dexcom G7 CGM with an insulin pump. Although his G7 told him that he had normal readings, he suffered a heart attack. At the hospital, he tested for extremely high glucose levels of 1651mg/dL, which his lawsuit calls a “fatal level.” His Dexcom G7 never alerted him.

He developed diabetic ketoacidosis, elevated potassium that caused his heart attack, kidney failure and lactic acidosis because of significantly elevated blood sugar. He never recovered and died from his injuries.

Michael’s wife, Jennifer Wisdom-Schepers, filed a wrongful death lawsuit on his behalf.

Dexcom Class Action Lawsuits

Dexcom class action lawsuits allege that Dexcom made false or misleading statements about how effective and accurate the Dexcom G6 and G7 were. These class actions differ from personal injury lawsuits because plaintiffs are either seeking refunds for Dexcom CGMs they bought or financial damages for stock losses.

Consumer Dexcom Class Action Lawsuit

Consumers in one class action want refunds for the purchase price of their CGMs. The lawsuit claims Dexcom falsely represented to consumers that its CGM technology accurately measured blood sugar levels and would warn if the levels were too low or too high.

Kirby McInerney Dexcom Lawsuit for Investors (Securities Class Action)

Kirby McInerney LLP is one of the law firms filing a class action lawsuit on behalf of investors who purchased Dexcom securities from Jan. 8, 2024, through Sept. 17, 2025. The class action lawsuit claims that Dexcom made design changes to the G6 and G7 that were unauthorized by the FDA.

These design changes made Dexcom CGMs less reliable, creating a health risk to people who use them. Furthermore, Dexcom downplayed the design issues and health risks posed by the G7. They are suing for financial damages from Dexcom’s fraudulent actions.

Can I File or Join a Dexcom Lawsuit?

You may be able to file or join a Dexcom G6 or G7 lawsuit if you or a loved one used a malfunctioning or inaccurate G6 or G7 CGMs, and it led to serious injuries.

You May Qualify if You or a Loved One:
  • Can document your Dexcom G6 or G7 malfunction, such as an app crash, missed alerts or other problems with the device.
  • Have lost wages, medical expenses or emotional damages because of injuries from a Dexcom G6 or G7 continuous glucose monitor.
  • Suffered hyperglycemia, hypoglycemia, diabetic ketoacidosis or other serious injuries because of Dexcom CGM malfunctions.
  • Was hospitalized or needed emergency care because of a malfunction or inaccurate readings from a G6 or G7.
  • Were not properly warned about the risks of using a Dexcom G6 or G7.

If you lost a loved one because of Dexcom CGM complications, you can file a wrongful death claim on their behalf. Even if you’re not sure you qualify, you should contact an attorney to confirm.

Dexcom Lawsuit Settlements and Potential Compensation

No settlements or jury trials have been announced or scheduled, so it is still too early to tell how much claimants can expect from Dexcom settlements or compensation.

Factors That Affect Dexcom Settlement Amounts
  • Amounts of economic losses
  • Documented medical bills, lost wages and lower earning capacity
  • Emotional damages, such as pain and suffering
  • Nature and severity of harm or injuries
  • Recalls or other regulatory notices
  • State laws on punitive damages and caps on economic damages
  • Strength of evidence
  • Whether the case is a stand-alone lawsuit or part of a multidistrict litigation (MDL)

Each case is unique, and only a licensed lawyer can tell you what affects settlement amounts for your specific case.

Differences Between Individual Dexcom Injury Lawsuits and Class Action Recoveries

Individual Dexcom lawsuits focus on physical injuries, such as DKA, hypo or hyperglycemia and death. Dexcom class actions focus on financial losses from securities, subscription costs or refunds for the device’s price.

How To File a Dexcom Lawsuit

The first step in filing a Dexcom lawsuit is to contact a lawyer. Consumer Notice can help match you with an experienced lawyer, and all you have to do is fill out a form or call the number on this page.

Collecting Medical Records and Device Data

When collecting medical records for a potential lawsuit, you will need to document your diabetes history as well as your injuries.

Examples of Medical Records
Complication Records:
This includes ER records, hospital admissions, urgent care visits for hypo/hyperglycemia, DKA, seizures or other events tied to a suspected G6 or G7 malfunction.
Diabetes Management Records:
Endocrinology notes show your A1c and diabetes treatment plan.
Data Records:
Download data from your G6 or G7 to keep as records, including glucose profiles, daily reports, events and alerts.
Device Records:
For sensors and transmitters, collect serial numbers, lot numbers and expiration dates. Take photos of packaging, adhesive failures or visible device damage.

A timeline that cross-references your medical events, device logs and any other medical findings can be powerful to help your lawyer prove your case.

What To Expect From the Dexcom Lawsuit Process

After you complete a brief form or call the number at the top of this page on Consumer Notice, we will match you with a representative from one of our vetted partner firms.

You’ll receive a free, no‑obligation case review for your potential Dexcom lawsuit from our partners. They will ask you about your experience with the Dexcom G6 or G7, what injuries you suffered, your damages and if you were hospitalized.

After the free consultation, the firm will tell you if you qualify, and they will file your lawsuit on your behalf and walk you through the next steps.

Dexcom Lawsuit FAQs

What is the lawsuit against Dexcom about?
Dexcom injury lawsuits claim the Dexcom G6 and G7 can malfunction and provide inaccurate readings. These malfunctions can lead to hypo or hyperglycemia, causing injuries such as diabetic ketoacidosis, seizures, coma, hospitalization and death.

Is there a Dexcom G7 class action lawsuit I can join?
There are two types of class action lawsuits you may be able to join: a consumer class action lawsuit that is suing for refunds of the purchase price of your equipment or subscriptions, or an investor class action that seeks financial damages from securities losses.

How long do I have to file a Dexcom lawsuit?
Each state has a different time limit, and it can be as little as one year from the time you were injured. Make sure you speak to a lawyer to get the exact time limit for your case.

What should I do if I think a Dexcom G7 or G6 problem injured me?
If you think a Dexcom CGM injured you, seek the proper medical treatment. Then, if you want to file a lawsuit, make sure you preserve all evidence and gather medical records before speaking to a licensed attorney.

Please seek the advice of a qualified professional before making decisions about your health or finances.
Last Modified: January 6, 2026

7 Cited Research Articles

Consumernotice.org adheres to the highest ethical standards for content production and references only credible sources of information, including government reports, interviews with experts, highly regarded nonprofit organizations, peer-reviewed journals, court records and academic organizations. You can learn more about our dedication to relevance, accuracy and transparency by reading our editorial policy.

  1. U.S. Food & Drug Administration. (2025, July 17). Continuous Glucose Monitor Receiver Recall: Dexcom, Inc. Removes Certain Dexcom G6, G7, ONE and ONE+ Receivers Due to Speaker Malfunction That May Cause Missed Alerts for Dangerous Blood Sugar Levels. Retrieved from https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/continuous-glucose-monitor-receiver-recall-dexcom-inc-removes-certain-dexcom-g6-g7-one-and-one#list
  2. U.S. Food & Drug Administration. (2025, June 16). Class 1 Device Recall Dexcom G6 Glucose Receiver. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=213506
  3. U.S. Food & Drug Administration. (2025, June 16). Class 1 Device Recall Dexcom G7 Glucose Receiver. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=213508
  4. U.S. Food & Drug Administration. (2025, March 25). Warning Letter: Dexcom, Inc. MARCS-CMS 700835 — March 04, 2025. Retrieved from https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dexcom-inc-700835-03042025
  5. U.S. District Court Southern District of California. (2024, January 30). Notice of Removal with Jury Demand. Higginbottom v. Dexcom, Inc. et al. CASE #: 3:24-cv-00195-WQH-BLM. Retrieved from https://ecf.casd.uscourts.gov/doc1/037019870513
  6. U.S. District Court Western District of Louisiana. (2024, January 30). Complaint. Dickson v. Dexcom, Inc. CASE #: 2:24-cv-00121-JDC-TPL. retrieved from https://ecf.lawd.uscourts.gov/doc1/08907639489
  7. U.S. Food & Drug Administration. (2019, October 29). MAUDE Adverse Event Report: Dexcom, Inc. Dexcom G6 CGM Sensor; Integrated Continuous Glucose Monitoring System. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=8864761&pc=QBJ